Advisory Committee on the Medical Uses of Isotopes: Call for Nominations, 55831-55832 [2010-22827]

Download as PDF jlentini on DSKJ8SOYB1PROD with NOTICES Federal Register / Vol. 75, No. 177 / Tuesday, September 14, 2010 / Notices centralized review under Executive Order 12866. This action does not preempt or modify any provision of state law; nor does it impose enforcement responsibilities on any state; nor does it diminish the power of any state to enforce its own laws. Accordingly, this action does not have federalism implications warranting the application of Executive Order 13132. The Deputy Administrator hereby certifies that this action will have no significant impact upon small entities whose interests must be considered under the Regulatory Flexibility Act, 5 U.S.C. 601 et seq. The establishment of aggregate production quotas for schedules I and II controlled substances is mandated by law and by international treaty obligations. The quotas are necessary to provide for the estimated medical, scientific, research and industrial needs of the United States, for export requirements and the establishment and maintenance of reserve stocks. While aggregate production quotas are of primary importance to large manufacturers, their impact upon small entities is neither negative nor beneficial. Accordingly, the Deputy Administrator has determined that this action does not require a regulatory flexibility analysis. This action meets the applicable standards set forth in Sections 3(a) and 3(b)(2) of Executive Order 12988 Civil Justice Reform. This action will not result in the expenditure by state, local, and tribal governments, in the aggregate, or by the private sector, of $126,400,000 or more in any one year, and will not significantly or uniquely affect small governments. Therefore, no actions were deemed necessary under the provisions of the Unfunded Mandates Reform Act of 1995. This action is not a major rule as defined by Section 804 of the Small Business Regulatory Enforcement Fairness Act of 1996. This action will not result in an annual effect on the economy of $100,000,000 or more; a major increase in costs or prices; or significant adverse effects on competition, employment, investment, productivity, innovation, or on the ability of United States-based companies to compete with foreignbased companies in domestic and export markets. Dated: September 2, 2010. Michele M. Leonhart, Deputy Administrator. [FR Doc. 2010–22785 Filed 9–13–10; 8:45 am] BILLING CODE 4410–09–P VerDate Mar<15>2010 16:38 Sep 13, 2010 Jkt 220001 OFFICE OF NATIONAL DRUG CONTROL POLICY Appointment of Members of Senior Executive Services Performance Review Board. Office of National Drug Control Policy [ONDCP]. ACTION: Notice of Appointments. AGENCY: Heading: Appointment of Members of Senior Executive Services Performance Review Board. SUMMARY: The following persons have been appointed to the ONDCP Senior Executive Service Performance Review Board: Dr. Terry Zobeck, Ms. Martha Gagne, Ms. Christine Leonard, and Mr. Patrick Ward. FOR FURTHER INFORMATION CONTACT: Please direct any questions to Linda V. Priebe, Deputy General Counsel (202) 395–6622, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503. Linda V. Priebe, Deputy General Counsel. [FR Doc. 2010–22794 Filed 9–13–10; 8:45 am] BILLING CODE 3180–02–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Call for Nominations U.S. Nuclear Regulatory Commission. ACTION: Call for Nominations. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is advertising for nominations for the patients’ rights advocate position on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nominees should have professional or personal experience with or knowledge about patient advocacy. Also, involvement or leadership with patient advocacy organizations is preferred. DATES: Nominations are due on or before November 15, 2010. NOMINATION PROCESS: Submit an electronic copy of resume or curriculum vitae, along with a cover letter, to Ms. Ashley Cockerham, ashley. cockerham@nrc.gov. The cover letter should describe the nominee’s current involvement with patients’ rights advocacy and express the nominee’s interest in the position. Please ensure that resume or curriculum vitae includes the following information, if applicable: education; certification; professional association membership SUMMARY: PO 00000 Frm 00096 Fmt 4703 Sfmt 4703 55831 and committee membership activities; and number of years, recentness, and type of setting for patient advocacy. FOR FURTHER INFORMATION CONTACT: Ms. Ashley Cockerham, U.S. Nuclear Regulatory Commission, Office of Federal and State Materials and Environmental Management Programs; (240) 888–7129; ashley.cockerham@nrc. gov. SUPPLEMENTARY INFORMATION: The patients’ rights advocate provides advice to NRC staff on patients’ issues associated with the regulation of medical applications of byproduct material. This advice includes ensuring patients’ rights are represented during the development and implementation of NRC medical-use policy. This individual is appointed based on his or her professional and personal experience with and/or knowledge about patient advocacy, involvement and/or leadership with patient advocacy organizations, and other information obtained in letters or during the selection process. Nominees should have the demonstrated ability to establish effective work relationships with peers and implement successful approaches to problem solving and conflict resolution. ACMUI members currently serve a four-year term and may be considered for reappointment to an additional term. The current membership is comprised of the following professionals: (a) Nuclear medicine physician; (b) nuclear cardiologist; (c) nuclear medicine physicist; (d) therapy medical physicist; (e) radiation safety officer; (f) nuclear pharmacist; (g) two radiation oncologists; (h) patients’ rights advocate; (i) Food and Drug Administration representative; (j) Agreement State representative; (k) health care administrator; and (l) diagnostic radiologist. For additional information about membership on the ACMUI, visit the ACMUI Membership Web page, http://www.nrc.gov/aboutnrc/regulatory/advisory/acmui/ membership.html. Nominees must be U.S. citizens and be able to devote approximately 160 hours per year to Committee business. Members are expected to attend semiannual meetings in Rockville, Maryland and to participate in teleconferences, as needed. Members who are not Federal employees are compensated for their service. In addition, these members are reimbursed for travel and correspondence expenses. Full-time Federal employees are reimbursed for travel expenses only. Security Background Check: The selected nominee will undergo a E:\FR\FM\14SEN1.SGM 14SEN1 55832 Federal Register / Vol. 75, No. 177 / Tuesday, September 14, 2010 / Notices thorough security background check. Security paperwork may take the nominee several weeks to complete. Nominees will also be required to complete a financial disclosure statement to assure that there are no conflicts of interest. This meeting will be webcast live at the Web address—http://www.nrc.gov. Week of October 18, 2010—Tentative Wednesday, October 20, 2010 Dated at Rockville, Maryland this 8th day of September, 2010. For the U.S. Nuclear Regulatory Commission. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. 2010–22827 Filed 9–13–10; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2010–0002] Sunshine Federal Register Notice Nuclear Regulatory Commission [NRC–2010– 0002]. DATES: Weeks of September 13, 20, 27, October 4, 11, 18, 2010. PLACE: Commissioners’ Conference Room, 11555 Rockville Pike, Rockville, Maryland. STATUS: Public and closed. AGENCY HOLDING THE MEETINGS: Week of September 13, 2010 Wednesday, September 15, 2010 8:45 a.m. Affirmation Session (Public Meeting) (Tentative). a. Final Update of the Commission’s Waste Confidence Decision (Tentative). Week of September 20, 2010—Tentative There are no meetings scheduled for the week of September 20, 2010. Week of September 27, 2010—Tentative Wednesday, September 29, 2010 1 p.m. Briefing on Resolution of Generic Safety Issue (GSI)—191, Assessment of Debris Accumulation on Pressurized Water Reactor (PWR) Sump Performance (Public Meeting). (Contact: Michael Scott, 301–415–0565). This meeting will be webcast live at the Web address—http://www.nrc.gov. jlentini on DSKJ8SOYB1PROD with NOTICES Week of October 4, 2010—Tentative There are no meetings scheduled for the week of October 4, 2010. Week of October 11, 2010—Tentative 16:38 Sep 13, 2010 Jkt 220001 These forms capture the terms and conditions of SBA’s new Secondary Market for First Mortgage Loan Pool Program. SBA needs this information in order to identify program participants, term of the financial transaction involving federal government guarantees and reporting on program efficiency, including the proper use of Recovery Act funds. Title: ‘‘Secondary Market for Section 504 First Mortgage Loan Pool.’’ Description of Respondents: Secondary Market Participants. Form Number: 2401, 2402, 2403, 2404. Annual Responses: 12,490. Annual Burden: 33,075. SUPPLEMENTARY INFORMATION: Jacqueline White, Chief, Administrative Information Branch. [FR Doc. 2010–22915 Filed 9–13–10; 8:45 am] BILLING CODE 8025–01–P Dated: September 9, 2010. Rochelle C. Bavol, Policy Coordinator, Office of the Secretary. SMALL BUSINESS ADMINISTRATION [FR Doc. 2010–22970 Filed 9–10–10; 4:15 pm] Wisconsin Disaster Number WI–00024 BILLING CODE 7590–01–P AGENCY: SMALL BUSINESS ADMINISTRATION Data Collection Available for Public Comments and Recommendations Notice and request for comments. ACTION: Thursday, October 14, 2010 9:30 a.m. Briefing on Alternative Risk Metrics for New Light Water Reactors (Public Meeting). (Contact: CJ Fong, 301–415–6249). VerDate Mar<15>2010 9:30 a.m. Briefing on Medical Issues (Public Meeting). (Contact: Michael Fuller, 301–415–0520). This meeting will be webcast live at the Web address—http://www.nrc.gov. * * * * * The schedule for Commission meetings is subject to change on short notice. To verify the status of meetings, call (recording)—(301) 415–1292. Contact person for more information: Rochelle Bavol, (301) 415–1651. * * * * * The NRC Commission Meeting Schedule can be found on the Internet at: http://www.nrc.gov/about-nrc/policymaking/schedule.html * * * * * The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If you need a reasonable accommodation to participate in these public meetings, or need this meeting notice or the transcript or other information from the public meetings in another format (e.g. braille, large print), please notify Angela Bolduc, Chief, Employee/Labor Relations and Work Life Branch, at 301– 492–2230, TDD: 301–415–2100, or by e-mail at angela.bolduc@nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. * * * * * This notice is distributed electronically to subscribers. If you no longer wish to receive it, or would like to be added to the distribution, please contact the Office of the Secretary, Washington, DC 20555 (301–415–1969), or send an e-mail to darlene.wright@nrc.gov. approval on a new and/or currently approved information collection. DATES: Submit comments on or before November 15, 2010. ADDRESSES: Send all comments regarding whether this information collection is necessary for the proper performance of the function of the agency, whether the burden estimates are accurate, and if there are ways to minimize the estimated burden and enhance the quality of the collection, to Jihoon Kim, Director Secondary Market & 504 Sales, Office of Financial Assistance, Small Business Administration, 409 3rd Street, 8th Floor, Washington, DC 20416. FOR FURTHER INFORMATION CONTACT: Jihoon Kim, Office of Financial Assistance, 202–205–7530 jihoon.kim@sba.gov Curtis B. Rich, Management Analyst, 202–205–7030 curtis.rich@sba.gov. In accordance with the Paperwork Reduction Act of 1995, this notice announces the Small Business Administration’s intentions to request SUMMARY: PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 [Disaster Declaration #12274 and #12275] U.S. Small Business Administration. ACTION: Amendment 1. This is an amendment of the Presidential declaration of a major disaster for Public Assistance Only for the State of Wisconsin (FEMA–1933– DR), dated 08/11/2010. Incident: Severe Storms, Tornadoes, and Flooding. Incident Period: 07/20/2010 through 07/24/2010. DATES: Effective Date: 09/07/2010. SUMMARY: E:\FR\FM\14SEN1.SGM 14SEN1

Agencies

[Federal Register Volume 75, Number 177 (Tuesday, September 14, 2010)]
[Notices]
[Pages 55831-55832]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-22827]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Call for 
Nominations

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Call for Nominations.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising 
for nominations for the patients' rights advocate position on the 
Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nominees 
should have professional or personal experience with or knowledge about 
patient advocacy. Also, involvement or leadership with patient advocacy 
organizations is preferred.

DATES: Nominations are due on or before November 15, 2010.

NOMINATION PROCESS:  Submit an electronic copy of resume or curriculum 
vitae, along with a cover letter, to Ms. Ashley Cockerham, 
ashley.cockerham@nrc.gov. The cover letter should describe the 
nominee's current involvement with patients' rights advocacy and 
express the nominee's interest in the position. Please ensure that 
resume or curriculum vitae includes the following information, if 
applicable: education; certification; professional association 
membership and committee membership activities; and number of years, 
recentness, and type of setting for patient advocacy.

FOR FURTHER INFORMATION CONTACT: Ms. Ashley Cockerham, U.S. Nuclear 
Regulatory Commission, Office of Federal and State Materials and 
Environmental Management Programs; (240) 888-7129; 
ashley.cockerham@nrc.gov.

SUPPLEMENTARY INFORMATION: The patients' rights advocate provides 
advice to NRC staff on patients' issues associated with the regulation 
of medical applications of byproduct material. This advice includes 
ensuring patients' rights are represented during the development and 
implementation of NRC medical-use policy. This individual is appointed 
based on his or her professional and personal experience with and/or 
knowledge about patient advocacy, involvement and/or leadership with 
patient advocacy organizations, and other information obtained in 
letters or during the selection process. Nominees should have the 
demonstrated ability to establish effective work relationships with 
peers and implement successful approaches to problem solving and 
conflict resolution. ACMUI members currently serve a four-year term and 
may be considered for reappointment to an additional term. The current 
membership is comprised of the following professionals: (a) Nuclear 
medicine physician; (b) nuclear cardiologist; (c) nuclear medicine 
physicist; (d) therapy medical physicist; (e) radiation safety officer; 
(f) nuclear pharmacist; (g) two radiation oncologists; (h) patients' 
rights advocate; (i) Food and Drug Administration representative; (j) 
Agreement State representative; (k) health care administrator; and (l) 
diagnostic radiologist. For additional information about membership on 
the ACMUI, visit the ACMUI Membership Web page, http://www.nrc.gov/about-nrc/regulatory/advisory/acmui/membership.html.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to Committee business. Members are expected to 
attend semi-annual meetings in Rockville, Maryland and to participate 
in teleconferences, as needed. Members who are not Federal employees 
are compensated for their service. In addition, these members are 
reimbursed for travel and correspondence expenses. Full-time Federal 
employees are reimbursed for travel expenses only.
    Security Background Check: The selected nominee will undergo a

[[Page 55832]]

thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to assure that there are no 
conflicts of interest.

    Dated at Rockville, Maryland this 8th day of September, 2010.

    For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2010-22827 Filed 9-13-10; 8:45 am]
BILLING CODE 7590-01-P